Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/29/1998 | CA2043033C Use of baclofen to obtain medication for the treatment of angina |
09/29/1998 | CA2020474C Antiinflammatory and/or antiallergic composition |
09/28/1998 | CA2233377A1 Nk-1 receptor antagonists for the treatment of delayed emesis |
09/27/1998 | CA2232499A1 Benzyloxy-substituted, fused n heterocycles, process for their preparation, and their use as bradykinin reception antagonists |
09/25/1998 | CA2233077A1 Pharmaceutical compounds |
09/25/1998 | CA2232930A1 Oral application of (+)-o-demethyltramadol as a pain killing drug |
09/24/1998 | WO1998041631A2 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
09/24/1998 | WO1998041617A1 Stimulation, culture and preservation of pancreatic and other cells |
09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
09/24/1998 | WO1998041528A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
09/24/1998 | WO1998041527A1 Pyrroloazepine compounds |
09/24/1998 | WO1998041525A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
09/24/1998 | WO1998041519A1 Novel cannabinoid receptor agonists |
09/24/1998 | WO1998041516A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
09/24/1998 | WO1998041512A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
09/24/1998 | WO1998041511A1 Pyridazinones as inhibitors of cyclooxygenase-2 |
09/24/1998 | WO1998041509A1 Methods and compositions for treating polycystic ovary syndrome |
09/24/1998 | WO1998041508A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
09/24/1998 | WO1998041507A1 Anti-convulsant isoquinolyl-benzamide derivatives |
09/24/1998 | WO1998041506A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
09/24/1998 | WO1998041505A1 Method for producing particles of pyrithione salts |
09/24/1998 | WO1998041501A1 2-alkylidene-19-nor-vitamin d compounds |
09/24/1998 | WO1998041500A1 2-alkyl-19-nor-vitamin d compounds |
09/24/1998 | WO1998041238A2 Methods and kits for treating and diagnosing leiomyomas |
09/24/1998 | WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
09/24/1998 | WO1998041231A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
09/24/1998 | WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
09/24/1998 | WO1998041223A1 N-methyl-d-aspartate receptor channel blockers and method for identifying such |
09/24/1998 | WO1998041217A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
09/24/1998 | WO1998041216A1 Composition for prevention of hepatic steatosis |
09/24/1998 | WO1998041214A1 Remedies for ischemic reflow disturbances |
09/24/1998 | WO1998041213A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
09/24/1998 | WO1998041212A1 New formulation |
09/24/1998 | WO1998041211A1 Methods and compositions for treating polycystic ovary syndrome |
09/24/1998 | WO1998041210A1 Sustained-release prostaglandin i derivative preparation |
09/24/1998 | WO1998041209A1 Protective agents for cells constituting nervous system |
09/24/1998 | WO1998041208A1 Compositions and methods for reducing ocular hypertension |
09/24/1998 | WO1998041207A1 Administration of an injectable antibiotic in the ear of an animal |
09/24/1998 | WO1998041206A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer |
09/24/1998 | WO1998041205A1 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis |
09/24/1998 | WO1998041204A1 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy |
09/24/1998 | WO1998041203A1 Ascorbic acid as an adjuvant in the removal of vascular occlusions |
09/24/1998 | WO1998041202A1 Hydroxybenzoate metabolites and hydroxybenzoate analogues as protectors against oxidative stress and chemotherapeutic drug cytotoxicity, cardiotoxicity and extravasation tissue injury |
09/24/1998 | WO1998041201A1 Therapeutic compositions |
09/24/1998 | WO1998041200A1 Therapeutic compositions |
09/24/1998 | WO1998041199A1 Decongestant for nose or eye |
09/24/1998 | WO1998041198A1 Method of inhibiting fibrosis with pyridoxal benzoyl hydrazone and analogs thereof |
09/24/1998 | WO1998041197A1 METHOD FOR TREATMENT OF $i(H. PYLORI) |
09/24/1998 | WO1998041196A1 Antiviral agents |
09/24/1998 | WO1998041193A1 Preparation of powder agglomerates |
09/24/1998 | WO1998041191A1 Aerosol preparation |
09/24/1998 | WO1998041171A1 Controlled release of pharmaceuticals in the anterior chamber of the eye |
09/24/1998 | WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
09/24/1998 | DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis |
09/24/1998 | DE19711800A1 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung Extension of the expression of transgenic proteins by modifying treatments |
09/24/1998 | DE19711616A1 Verbessertes Verfahren zur Herstellung von Thiazolidindionen An improved process for the preparation of thiazolidinediones |
09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
09/24/1998 | CA2285988A1 Antiviral agents |
09/24/1998 | CA2285701A1 .beta.-catenin, tcf-4, and apc interact to prevent cancer |
09/24/1998 | CA2284218A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
09/24/1998 | CA2284039A1 Methods and kits for treating and diagnosing leiomyomas |
09/24/1998 | CA2284035A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
09/24/1998 | CA2283961A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
09/24/1998 | CA2283882A1 Method for producing particles of pyrithione salts |
09/24/1998 | CA2283797A1 Novel cannabinoid receptor agonists |
09/24/1998 | CA2283738A1 Ascorbic acid as an adjuvant in the removal of vascular occlusions |
09/24/1998 | CA2283732A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer |
09/24/1998 | CA2283691A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
09/24/1998 | CA2283682A1 Anti-convulsant isoquinolyl-benzamide derivatives |
09/24/1998 | CA2283438A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
09/24/1998 | CA2283297A1 New formulation |
09/24/1998 | CA2283100A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
09/24/1998 | CA2283098A1 Methods and compositions for treating polycystic ovary syndrome |
09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
09/24/1998 | CA2255024A1 Protective agents for cells constituting nervous system |
09/24/1998 | CA2254875A1 Pyrroloazepine compounds |
09/23/1998 | EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein |
09/23/1998 | EP0866063A1 10, 11-Methanodibenzosuberane derivatives used as chemosensitizing agents |
09/23/1998 | EP0865790A2 Use of triazolopyridazine derivatives in the manufacture of a medicament for the treatment of atopic dermatitis |
09/23/1998 | EP0865789A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine |
09/23/1998 | EP0865788A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
09/23/1998 | EP0865609A1 Method of diagnosing and treating epithelioma |
09/23/1998 | EP0865492A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
09/23/1998 | EP0865489A1 Modified vegf antisense oligonucleotides |
09/23/1998 | EP0865447A1 Cyclic dodecapeptide and process for the preparation thereof |
09/23/1998 | EP0865446A1 Agents for promoting bone formation |
09/23/1998 | EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
09/23/1998 | EP0865440A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
09/23/1998 | EP0865439A1 Combinatorial libraries having aminodiol monomer subunits |
09/23/1998 | EP0865431A2 Compounds |
09/23/1998 | EP0865430A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
09/23/1998 | EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis |
09/23/1998 | EP0865428A1 Vitamin d analogues |
09/23/1998 | EP0865427A1 Synthesis of 1alpha-hydroxy vitamin d |
09/23/1998 | EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
09/23/1998 | EP0865425A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them |
09/23/1998 | EP0865422A1 Amino alcohol derivatives, methods of producing said derivatives and medicaments containing them |
09/23/1998 | EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |